Skip to main content

Macrophage-Derived IL-18 Targeting for the Treatment of Crohn's Disease

Buy Article:

$55.00 plus tax (Refund Policy)

Crohn's disease is an inflammatory bowel disease associated with several changes in the immune system, including an increased number of infiltrating macrophages. These macrophages release a variety of proinflammatory cytokines, such as tumor necrosis factor-α (TNF-α), macrophage infiltrating factor (MIF), interleukin (IL)-6, IL-12 and IL-18, which are critically involved in the onset and the development of Crohn's disease. We here focus on the role of macrophages, especially macrophagederived IL-18 in both patients with Crohn's disease and a murine model of Crohn's disease.

No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: crohns disease; il-18; immunotoxin; proinflammatory cytokines; targeting

Document Type: Review Article

Publication date: 2003-06-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more